Researchers generated an Immunoscore (IS) based on the density of CD3+ and CD8+ T-cell effectors within the tumor, as well as its invasive margin, and developed a colon cancer recurrence risk model accordingly (47, 48). This evidence concerns the gene CD8A and malignant colon neoplasm.